- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Recurrent Prostate Cancer in New Zealand
Total 8609 results
-
Curium US LLCRecruitingProstate Cancer | Prostate Adenocarcinoma | Biochemical Recurrence of Malignant Neoplasm of ProstateUnited States
-
ImaginAb, Inc.CompletedMetastatic Prostate CancerUnited States
-
Columbia UniversityActive, not recruitingMetastatic Prostate CancerUnited States
-
Steba Biotech S.A.WithdrawnLocalized Prostate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterCompletedProstate Cancer | Localized Prostate CancerUnited States
-
Cytogen CorporationUnknownMetastatic Prostate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingProstate Cancer | Castration-resistant Prostate Cancer | Prostate Adenocarcinoma | Prostate Cancer Metastatic | Prostate NeoplasmUnited States
-
Accuray IncorporatedCompletedProstatic Neoplasms | Prostate Cancer | Prostate Neoplasms | Cancer of the Prostate | Prostatic CancerUnited States
-
National Cancer Institute (NCI)CompletedProstate Adenocarcinoma | Stage I Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Assembly BiosciencesNot yet recruitingRecurrent Genital Herpes Simplex Type 2New Zealand
-
ORIC PharmaceuticalsRecruitingMetastatic Prostate Cancer | Neuroendocrine Prostate CancerUnited States
-
SanofiCompletedProstate Cancer MetastaticIndia
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedCastration Resistant Prostate Cancer | Prostate Carcinoma Metastatic to the BoneUnited States
-
BayerRecruitingBiochemically Recurrent Prostate CancerAustria, Spain, United States, Australia, Brazil, France, Germany, Taiwan, Denmark, China, Netherlands, Portugal, Japan, Canada, Finland, Italy, Hungary, United Kingdom, Poland, Israel, New Zealand, Sweden, Belgium, Czechia
-
Trans Tasman Radiation Oncology GroupNational Health and Medical Research Council, Australia; Novartis Pharmaceuticals and other collaboratorsCompletedProstate CancerAustralia, New Zealand
-
SanofiCompletedProstate CancerUnited States
-
University of Rochester NCORP Research BaseNational Cancer Institute (NCI)RecruitingStage I Prostate Cancer AJCC v8 | Stage II Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8United States
-
Memorial Sloan Kettering Cancer CenterMillennium Pharmaceuticals, Inc.CompletedMetastatic Castration-Resistant Prostate CancerUnited States
-
Astellas Pharma Global Development, Inc.CompletedProstate Cancer | Castration-resistant Prostate Cancer | Metastatic Prostate CancerSpain, Taiwan, France, Algeria, Argentina, Australia, Austria, Brazil, Canada, Colombia, Egypt, Germany, Indonesia, Israel, Italy, Korea, Republic of, Lebanon, Mexico, Netherlands, New Zealand, Oman, Peru, Philippines, Saudi Arabia, Sin... and more
-
Memorial Sloan Kettering Cancer CenterCompletedCancer | Prostate | Hormonal CyclingUnited States
-
St Vincent's Hospital, SydneyRecruitingMetastatic Prostate CancerAustralia
-
Tulane UniversityBlue Earth DiagnosticsCompletedMetastatic Castration-resistant Prostate CancerUnited States
-
Peter MacCallum Cancer Centre, AustraliaUnknownProstate CancerAustralia, New Zealand
-
Suzhou Kintor Pharmaceutical Inc,CompletedMetastatic Castrate Resistant Prostate Cancer (mCRPC)United States
-
Roswell Park Cancer InstituteNational Comprehensive Cancer NetworkRecruitingCastration-Resistant Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVA Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8United States
-
Sapience TherapeuticsRecruitingBreast Cancer | Glioblastoma | Prostate Cancer | Brain Cancer | Glioblastoma Multiforme | GBM | Metastatic Breast Cancer | Recurrent Glioblastoma | Metastatic Melanoma | Metastatic Prostate Cancer | Prostate Cancer Metastatic | Newly Diagnosed Glioblastoma | Melanoma Stage IV | Melanoma RecurrentUnited States, United Kingdom
-
BayerCompletedMetastatic Castration-resistant Prostate Cancer (mCRPC)United States
-
Exosome Diagnostics, Inc.Yale UniversitySuspendedMetastatic Castrate Resistant Prostate CancerUnited States
-
Jodi Layton, MDEMD SeronoTerminatedMetastatic Castration-resistant Prostate CancerUnited States
-
Memorial Sloan Kettering Cancer CenterProgenics Pharmaceuticals, Inc.CompletedProstate Cancer | Metastatic Castration-Resistant Prostate Cancer (mCRPC)United States
-
Masonic Cancer Center, University of MinnesotaCompletedPhase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate CancerMetastatic Prostate CancerUnited States
-
St Vincent's Hospital, SydneyRecruitingCastration-resistant Prostate Cancer | Homologous Recombination DeficiencyAustralia
-
Janux TherapeuticsRecruitingProstate Cancer | Metastatic Castration-resistant Prostate Cancer | Castration Resistant Prostatic CancerUnited States, Australia
-
Royal North Shore HospitalTerminatedMetastatic Castrate- Resistant Prostate CancerAustralia
-
BayerCompletedMetastatic Castration Resistant Prostate Cancer (mCRPC)United States
-
Accuray IncorporatedCompletedProstatic Neoplasms | Prostate Cancer | Prostate Neoplasms | Cancer of the Prostate | Prostatic CancerUnited States
-
Christopher Sweeney, MBBSSanofi; Hoosier Cancer Research Network; Walther Cancer InstituteTerminatedMetastatic Prostate CancerUnited States, Canada
-
Duke UniversityCompleted
-
DendreonCompletedHormone Refractory Prostate Cancer | Castration-resistant Prostate Cancer | Prostate Cancer MetastaticUnited States
-
Hoffmann-La RocheCompleted
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)RecruitingBiochemically Recurrent Prostate Carcinoma | Metastatic Prostate Carcinoma | Prostate Adenocarcinoma | Stage IVB Prostate Cancer AJCC v8United States
-
National Human Genome Research Institute (NHGRI)Completed
-
Ascenta TherapeuticsCompletedHormone Refractory Prostate CancerUnited States
-
Advanced Accelerator ApplicationsCompletedProstate Cancer MetastaticUnited States
-
Bristol-Myers SquibbCompletedMetastatic Prostate CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedStage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer | PSA Level Five to Ten | PSA Level Less Than Five | PSA Level Ten to FiftyUnited States
-
Genentech, Inc.RecruitingMetastatic Prostate Cancer | Advanced Prostate CancerKorea, Republic of, United States, Australia
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedProstate Cancer | Hormone Refractory Prostate CancerUnited States
-
National Cancer Institute (NCI)CompletedAdenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
BayerCompletedNon-metastatic Prostate Cancer | Non-metastatic Castration-resistant Prostate CancerUnited States